- Home
- BHVN vs PCH Comparison
BHVN vs PCH Comparison
Compare BHVN & PCH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BHVN
- PCH
- Stock Information
- Founded
- BHVN 2013
- PCH 1903
- Country
- BHVN United States
- PCH United States
- Employees
- BHVN N/A
- PCH N/A
- Industry
- BHVN Biotechnology: Pharmaceutical Preparations
- PCH Real Estate Investment Trusts
- Sector
- BHVN Health Care
- PCH Real Estate
- Exchange
- BHVN Nasdaq
- PCH Nasdaq
- Market Cap
- BHVN 3.6B
- PCH 3.1B
- IPO Year
- BHVN 2017
- PCH N/A
- Fundamental
- Price
- BHVN $39.17
- PCH $42.39
- Analyst Decision
- BHVN Strong Buy
- PCH Buy
- Analyst Count
- BHVN 13
- PCH 5
- Target Price
- BHVN $63.00
- PCH $48.20
- AVG Volume (30 Days)
- BHVN 1.2M
- PCH 459.0K
- Earning Date
- BHVN 02-27-2025
- PCH 01-27-2025
- Dividend Yield
- BHVN N/A
- PCH 4.22%
- EPS Growth
- BHVN N/A
- PCH N/A
- EPS
- BHVN N/A
- PCH 0.20
- Revenue
- BHVN N/A
- PCH $1,058,432,000.00
- Revenue This Year
- BHVN N/A
- PCH N/A
- Revenue Next Year
- BHVN $197.13
- PCH $0.66
- P/E Ratio
- BHVN N/A
- PCH $214.59
- Revenue Growth
- BHVN N/A
- PCH 3.49
- 52 Week Low
- BHVN $26.80
- PCH $37.06
- 52 Week High
- BHVN $62.21
- PCH $48.08
- Technical
- Relative Strength Index (RSI)
- BHVN 51.03
- PCH 59.17
- Support Level
- BHVN $35.01
- PCH $38.05
- Resistance Level
- BHVN $39.36
- PCH $43.06
- Average True Range (ATR)
- BHVN 2.07
- PCH 0.87
- MACD
- BHVN 0.50
- PCH 0.52
- Stochastic Oscillator
- BHVN 77.83
- PCH 86.13
About BHVN Biohaven Ltd.
Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. Its products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder, and others.
About PCH PotlatchDeltic Corporation
PotlatchDeltic Corp is a REIT that owns and manages forestland in Alabama, Arkansas, Idaho, Minnesota, and Mississippi. Potlach operates in three segments. The timberlands segment covers the planting and harvesting of trees, as well as the construction and maintenance of roads. The wood products segment manufactures and distributes lumber, plywood, and other wood products. The real estate segment covers the sales generated from company-owned timberlands, as well as commercial and residential properties. The timberlands and the wood product segments combined drive the majority of the company's revenue.